The Election Commission has stated that seizures related to cash, liquor, drugs, and other inducements have exceeded 650 crore rupees in the lead-up to the upcoming state assembly elections and by-elections across multiple states. These seizures include cash, liquor, narcotics, precious metals...
assam
cash seizures
election commission
elections
kerala
liquor seizures
narcotics seizures
political finance
puducherry
quick response teams
seizures
state assembly elections
surveillance teams
tamil nadu
west bengal
Kolkata, April 1 Police have seized cash, liquor, narcotics, and other items worth over ₹274 crore in West Bengal, as part of intensified enforcement measures ahead of the assembly elections, officials said on Wednesday.The total value of seizures since February 26 stands at ₹274.12 crore...
New Delhi, March 11 Harish Rana, 32, was an avid gym-goer and football player, and was pursuing a B.Tech degree at Panjab University in 2013 when he fell from the fourth floor of his rented accommodation and sustained a brain injury, leading to a coma.The Supreme Court on Wednesday permitted...
aiims delhi
bedsores
brain injury
coma
diffuse axonal injury
ghaziabad
harish rana
jai prakash narayan trauma centre
life support withdrawal
nasogastric tube
passive euthanasia
pgi chandigarh
punjab university
seizures
tracheostomy
New Delhi, February 26 Alembic Pharmaceuticals announced on Thursday that it has received approval from the US health regulator to market a generic medication for seizures.The drug company has received final approval from the US Food & Drug Administration (USFDA) for its abbreviated new drug...
New Delhi, February 25 Drug firm Lupin announced on Wednesday that it has received approval from the US health regulator to market a generic medication to treat seizures.The Mumbai-based firm has received approval from the USFDA for its abbreviated new drug application (ANDA) for Brivaracetam...
anda
brivaracetam
briviact
bse
drug approval
generic medication
india
lupin
oral solution
pharmaceutical industry
pharmaceutical sales
seizures
us market
usfda